A guardian molecule ensures that liver cells do not lose their identity. This has been discovered by researchers from the ...
Researchers from the Francis Crick Institute have found that some particularly aggressive lung cancer cells can develop their ...
Exelixis reported $515.2M in net product revenues in Q4'24, a 20% increase over net product revenues for Q4'23. See why I ...
“These medicines will give people more treatment options and help them to live well for longer,” says Pharmac’s Director Equity and Engagement, Dr Nicola Ngawati. “We expect about 180 people will ...
Tragically, it claims the lives of 9,558 people annually, with over 70% succumbing within a year of being diagnosed. Just one ...
Tragically, it claims the lives of 9,558 people annually, with over 70% succumbing within a year of being diagnosed. Just one ...
Sadly the disease will kill 9,558 people every year with just over 70% dying within 12 months of their diagnosis. One in 10 ...
Rare cancers are less known and pose challenges due to limited research and diagnostic difficulties. Environmental factors, ...
Dr. Jonathan R. Strosberg, discussed results of the CABINET trial evaluating Cabometyx versus placebo in advanced ...
Some people use Zollinger-Ellison syndrome and gastrinoma interchangeably. Learn the similarities and differences between the ...
The combination of chemotherapy and radioembolization appeared safe and effective in patients with well-differentiated, liver-dominant, grade 3 NETs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results